Mr Howes brings more than 20 years of senior-level pharmaceutical experience to Inotek, most recently serving as president of the Americas Region for Bausch & Lomb where he had full commercial responsibility for the vision care, surgical and pharmaceuticals segments in the US, Canada, Latin America and South America.
Jerry Karabelas, Inotek’s chairman of the board of directors, said: “We are very pleased to have attracted someone of Paul’s caliber at a time when Inotek is advancing multiple programs through clinical development.
“Paul brings a long history of successful enterprise management and his ophthalmology experience at both Bausch & Lomb and Merck will be of particular importance to Inotek. Importantly, with Paul’s hiring, we have completed the transformation of the executive management team and the company is now well positioned to advance several key candidates through clinical proof of concept.”